Company / Working Capital per Share
Ventyx Biosciences, Inc. Working Capital per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.17
FY2024
5-year range
-$0.58 / $19.55
FY2020-FY2024
Trend
-23.4%
vs FY2023
Sector context
#132 of 208
Health Care
What the data says
At $3.17, Ventyx Biosciences, Inc.'s working capital per share ranks #132 of 208 in the Health Care sector. Working Capital per Share has declined for 3 consecutive years, from $19.55 in FY2021 to $3.17 in FY2024.
Based on SEC 10-K filings.
3.17 in FY2024 with a 3-year CAGR of -45.5%.
Declined from $5.99 to $3.17 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -45.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#132 of 208 in Health CareTop 63% of 208This company $3.17 Sector average $160.16
▼
-98.0% below sector average
Key checks
Key Insights
- Ventyx Biosciences, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2024, working capital per share decreased 23.4% year-over-year.
- Ranks #132 out of 208 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.17 | -23.4% |
| FY2023 | $4.14 | -31.0% |
| FY2022 | $5.99 | -69.4% |
| FY2021 | $19.55 | +3457.2% |
| FY2020 | -$0.58 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026